Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vycor Medical's interest expense for the
three
months ended in Jun. 2026 was $ -0.03 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.10 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vycor Medical's Operating Income for the
three
months ended in Jun. 2026 was $ 0.01 Mil. Vycor Medical's Interest Expense for the
three
months ended in Jun. 2026 was $ -0.03 Mil.
Vycor Medical's Interest Coverage for the quarter that ended in Jun. 2026 was 0.27.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Vycor Medical (OTCPK:VYCO) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Warning Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Vycor Medical Incs earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.
Vycor Medical Interest Expense Historical Data
* Premium members only.
The historical data trend for Vycor Medical's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (VYCO) has a Interest Expense of $-0.10 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Vycor Medical and its competitors.
Is Vycor Medical's Interest Expense too high?
Vycor Medical's current Interest Expense is $-0.10 Mil.
How does Vycor Medical's Interest Expense compare to BTCY and FEED?
Vycor Medical's Interest Expense of $-0.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Vycor Medical and its competitors. Vycor Medical's current Interest Expense is $-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vycor Medical stock overvalued right now?
Based on GuruFocus' analysis, Vycor Medical (VYCO) is currently considered Possible Value Trap. The stock's GF Value™ is $0.11, compared to a current price of $0.07 — trading 38.2% below its estimated fair value. The current Interest Expense is $-0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Vycor Medical (VYCO), the current Interest Expense is $-0.10 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYCO has been successfully added to your 
